Carlisle Companies Incorporated (CSL)

Current ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total current assets US$ in thousands 3,408,100 3,657,000 2,692,900 2,152,300 2,245,000 2,770,900 2,532,600 2,228,800 2,150,900 2,081,800 2,512,500 2,144,500 2,209,300 2,140,200 2,152,900 2,608,600 1,752,000 2,107,400 1,922,200 1,877,300
Total current liabilities US$ in thousands 1,186,300 875,600 1,045,300 930,000 1,078,400 1,552,100 1,259,700 1,188,600 1,169,500 851,300 761,700 660,100 646,200 645,700 613,900 602,700 899,000 692,200 649,900 633,200
Current ratio 2.87 4.18 2.58 2.31 2.08 1.79 2.01 1.88 1.84 2.45 3.30 3.25 3.42 3.31 3.51 4.33 1.95 3.04 2.96 2.96

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $3,408,100K ÷ $1,186,300K
= 2.87

The current ratio of Carlisle Companies Inc. has shown fluctuations over the past eight quarters, ranging from a low of 1.79 in Q3 2022 to a high of 4.18 in Q3 2023. The current ratio measures the company's ability to cover its short-term liabilities with its current assets. A ratio above 1 indicates that the company has more current assets than current liabilities, which is generally a positive sign.

In Q4 2023, the current ratio stands at 2.87, indicating that the company has approximately $2.87 in current assets for every $1 in current liabilities. This is a relatively strong current ratio and suggests that Carlisle Companies Inc. is in a favorable position to meet its short-term obligations. The significant increase from the previous quarter (Q3 2023) implies an improvement in the company's liquidity position.

Overall, the trend in the current ratio of Carlisle Companies Inc. has been fluctuating but generally improving over the past eight quarters, with some quarters showing more stability and strength in liquidity than others. Investors and analysts may find comfort in the company's ability to maintain a healthy level of current assets relative to its current liabilities.


Peer comparison

Dec 31, 2023

Company name
Symbol
Current ratio
Carlisle Companies Incorporated
CSL
2.87
West Pharmaceutical Services Inc
WST
2.88